[P-210] Overcoming effect of combination of aldo-keto reductase and proteasome inhibitors on development of cisplatin resistance in breast cancer cells

^○Toshiyuki Matsunaga¹, Mio Kobayashi², Hana Iwasa², Kazuhiro Iguchi³, Satoshi Endo², Akira Ikari² (1.Education Center of Green Pharmaceutical Sciences, Gifu Pharmaceutical University, 2.Laboratory of Biochemistry, Gifu Pharmaceutical University, 3.Laboratory of Community Pharmacy, Gifu Pharmaceutical University)

キーテクノロジー：細胞毒性試験

アルドケト還元酵素、シスプラチン、乳がん